Rekola, Merituuli
Korhonen, Kati
Unkila-Kallio, Leila
Alfthan, Henrik
Stefanovic, Vedran
Tiitinen, Aila
Mikkola, Tomi S.
Savolainen-Peltonen, Hanna
Funding for this research was provided by:
University of Helsinki
Article History
Received: 12 October 2023
Accepted: 20 December 2023
First Online: 20 January 2024
Declarations
:
: The study was conducted according to the Declaration of Helsinki, with informed consent from the participants, and received approval from the Helsinki University Ethics Committee prior to its start.
: Not applicable.
: HS-P has been a member of the advisory board of Ferring Pharmaceuticals and a consultant to Merck and Orion.